Scribd Logo
Upload

Welcome to Scribd!

  • 166 views

    Pharmaceutical Sector - Saudi Arabia: Outlook and Current Trends

    Uploaded by

    AliMirza
    The pharmaceutical sector in Saudi Arabia is growing due to factors such as population growth, increased health awareness among consumers, and government investment in healthcare. Consumers are more proactive about their health and seek treatment and supplements to prevent diseases. Major pharmaceutical companies like Novartis and Saudi Pharmaceutical Industries have the largest market shares. The government supports the industry through initiatives, training programs, and investments in new cities and healthcare facilities. Overall, the sector is expected to see continued strong sales and growth.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Pharmaceutical Sector - Saudi Arabia: Outlook and Current Trends

    Uploaded by

    AliMirza
    166 views3 pages
    The pharmaceutical sector in Saudi Arabia is growing due to factors such as population growth, increased health awareness among consumers, and government investment in healthcare. Consumers are more proactive about their health and seek treatment and supplements to prevent diseases. Major pharmaceutical companies like Novartis and Saudi Pharmaceutical Industries have the largest market shares. The government supports the industry through initiatives, training programs, and investments in new cities and healthcare facilities. Overall, the sector is expected to see continued strong sales and growth.

    Original Description:

    Overview of Pharma sector in Saudi Arabia

    Original Title

    Sanofi in Saudi Arabia

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The pharmaceutical sector in Saudi Arabia is growing due to factors such as population growth, increased health awareness among consumers, and government investment in healthcare. Consumers are more proactive about their health and seek treatment and supplements to prevent diseases. Major pharmaceutical companies like Novartis and Saudi Pharmaceutical Industries have the largest market shares. The government supports the industry through initiatives, training programs, and investments in new cities and healthcare facilities. Overall, the sector is expected to see continued strong sales and growth.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    166 views3 pages

    Pharmaceutical Sector - Saudi Arabia: Outlook and Current Trends

    Uploaded by

    AliMirza
    The pharmaceutical sector in Saudi Arabia is growing due to factors such as population growth, increased health awareness among consumers, and government investment in healthcare. Consumers are more proactive about their health and seek treatment and supplements to prevent diseases. Major pharmaceutical companies like Novartis and Saudi Pharmaceutical Industries have the largest market shares. The government supports the industry through initiatives, training programs, and investments in new cities and healthcare facilities. Overall, the sector is expected to see continued strong sales and growth.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 3

    Pharmaceutical sector - Saudi Arabia

    Outlook and current trends:


    Increased consumer sophistication & proactive treatment:
    Saudi Arabia is a market that is experiencing rapid population growth. We are also witnessing a more proactive
    approach on part of consumers towards healthcare.
    We have also witnessed a shift in attitude of the general population towards health and wellness. People are
    becoming more aware of issues pertaining to being overweight, smoking and also certain lifestyle diseases like
    diabetes.
    They are becoming more sophisticated regarding symptoms, causes and treatment. Hence there is an increased
    willingness to self-medicate, boosting the utilization of OTC drugs.
    Some consumers are now willing to stave off potential future ailments by opting for calcium or vitamin
    supplements.
    Hajj:
    For the local populace, Hajj (Annual pilgrimage for Muslims) is also a season where people fear the influx of disease
    from various countries. There have been a few inoculation campaigns targeting Saudis and expat residents for
    certain diseases near Hajj. There is no formidable data to back up such concerns but it remains a genuine concern
    for locals especially for people residing in the Western province of Saudi Arabia.
    Distribution mix:
    Chemists/ Pharmacists remain on top among distribution channels; however, post 2010 with increased awareness
    on fitness and alternative medicine consumers are opting for health-food shops which have demonstrated strong
    performance in weight management and allergy care. Internet retail is yet to kick off in KSA and based on data
    from 2010 represents only 0.1 % contribution to the distribution mix.
    Government initiatives and Economic growth:
    The Saudi Government through the Ministry of Health runs many initiatives for a number of diseases on an yearly
    or bi-annual basis. Nowadays, there is special emphasis on healthcare awareness and prevention of various
    diseases like STDs & Hepatitis etc.
    The ministry also regularly organizes seminars for local practitioners and invests a substantial amount in training
    doctors and nurses as well as pharmacists.
    It is quite evident that government spending in healthcare is on a constant rise with high investments in medical
    education and infrastructure.
    For example, development of public healthcare facilities is on the rise which is in line with the Governments plans
    to establish 5 entirely new cities in previously under-developed areas. Such cities will also be provided with
    neighborhood clinics, hospitals and medical universities.
    The Saudi government also runs a scholarship program where students who obtain admission in reputable foreign
    universities are fully funded by the government to pursue their academic requirements which includes a fixed
    monthly stipend as well.
    Overall, in terms of Pharmaceutical sector growth, we predict stronger sales as economic growth and population
    figures of KSA are on the rise compounded by the emergence of five new cities in the long term.

    Pharmaceutical industry overview:
    Market Share:
    Consumers are constantly opting for leading brands and at the moment Novartis (11.3 %) and Saudi
    Pharmaceutical Industries and Medical Appliances Co. (10.8 %) rank on top in terms of Retail value RSP and are the
    only companies with a share in double digits in the Kingdom for the year 2011. They are followed by GSK (9.1%),
    Reckitt-Benckiser (7.3 %), Tabuk Pharmaceutical Manufacturing Co. (3.7 %) and Merck & Co. (3.4 %).
    Sanofis market share has remained relevantly marginal at around 0.9% over the period 2006-2011.
    If we look at brands by various firms, GSKs Panadol is on top with a 7.1% share of Retail Value Rsp. Dettol 3.9%
    (Reckitt-Benckiser), Voltaren 2.8% (Ciba-Geigy), Otrivin 2.2% (Novartis), Rofenac 2.0 % (SPIMACO) round off the
    top five in particular order. (Based on data for Year 2010)
    (For a more detailed look at media spends within the Pharmaceutical industry, please refer to attached document titled Consumer Health Market shares.xls)
    Media Spends:
    Based on estimates of aggregate media spends within KSA for the period 2010-2011, Riyadh Pharma was the
    highest spender. Pfizer, SPIMACO, Al Haya were at par with significantly lower but yet substantial investment in
    media. Sanofi is also close-by in terms of magnitude of investment in advertising their products.
    (For a more detailed look at media spends within the Pharmaceutical industry, please refer to attached document Consumer Health Media Spends estimates.xls)
    Local Regulations:
    The Saudi ministry of Health divides pharmaceuticals into three groups:
    Medicines and Pharmaceuticals
    o Rx (Require Prescriptions)
    o OTC
    Herbal Medicines
    Cosmeceuticals
    Pricing is also regulated by the Ministry of Health with an aim to ensure lowest prices possible. For imports the
    ministry assesses the prices in several countries and selects the lowest available price.
    Advertising of Pharmaceutical and medicinal products is prohibited on non-medical media, including TV and radio.
    Hence, firms invest in promotion via seminars, medical magazines and also target healthcare workers.
    Pharma firms also utilize sales pushes to chemists/pharmacists like bulk-buy bonuses as they cannot target
    consumers with price promotions. Sales reps also visit doctors and pharmacists on a regular basis offering free
    samples, leaflets and gifts as well.
    Exceptions: Some Pharma firms have obtained permission from the Ministry of Health to advertise their brands
    locally. For example: Panadol (GSK), Sedergine (UPSA), Fevadol (SPIMACO) etc. Such brands are mostly analgesics,
    cough, cold and allergy remedies. Drapolene (by Wellcome for diaper rashes) and Gaviscon (Antacid by GSK)

    You might also like